January 2010 in “Chinese Journal of Hospital Pharmacy” This study found that finasteride test and reference tablets are bioequivalent in healthy male volunteers, with no significant differences in their pharmacokinetic parameters.
January 2007 in “Pharmaceutical Journal of Chinese People's Liberation Army” In this study, the researchers found that two formulations of finasteride tablets were bioequivalent in Chinese healthy male volunteers.
January 2005 in “Zhongguo yaofang” This study found that domestic and imported finasteride tablets were bioequivalent in terms of their pharmacokinetic parameters and relative bioavailability in human volunteers.
January 2005 in “Chinese New Drugs Journal” This study concluded that locally manufactured finasteride tablets are bioequivalent to imported ones based on pharmacokinetic profiles in male volunteers.
January 2005 in “Zhōnghuá yàoxué zázhì” This study concluded that two different finasteride tablet formulations are bioequivalent based on their pharmacokinetic profiles in a crossover trial with male subjects.
January 2005 in “Journal of Elinical Research” This study found that the pharmacokinetic profile of finasteride capsules and tablets in healthy volunteers is bioequivalent.
January 2004 in “Chinese Journal of New Drugs and Clinical Remedies” This study concluded that two different brands of finasteride tablets are bioequivalent based on their pharmacokinetic parameters and relative bioavailability.
January 2003 in “The Chinese Journal of Clinical Pharmacology” In this study, the authors concluded that the tested and reference finasteride tablets showed bioequivalence in healthy male volunteers.